Silu Yang

947 citations
16 papers · 630 · 1 hit paper · h-index 9

Impact in

Papers in

Silu Yang

16 papers receiving 616 citations

Silu Yang's Hit Papers

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial 2024 · 186 citations
1860+1Years since publication50100150

Peers

Silu Yang
Comparison fields: 5 of 51
  • Oncology 188
  • Developmental Neuroscience 19
  • Pulmonary and Respiratory Medicine 142
  • Otorhinolaryngology 22
  • Public Health, Environmental and Occupational Health 129
Replace Youcef Ouadah with:
Youcef Ouadah United States
Jarred Thomas Burkart United States
Shari Orlanski Israel
K Welte United States
Shigenori Furukawa Japan
Yukari Taniyama Japan
Csaba L. Mártonyi United States
Chie Kikutake Japan
Silu Yang relative to Youcef Ouadah United States Youcef Ouadah's profile →
Citations per field
00.5×5×11×
Youcef Ouadah · 1×
Citations per year

Countries citing papers authored by Silu Yang

Since Specialization
Citations

This map shows the geographic impact of Silu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silu Yang more than expected).

Fields of papers citing papers by Silu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silu Yang. The network helps show where Silu Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Silu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silu Yang Line = papers co-authored together Silu Yang links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
Hit paper breakdown →
2024186
2 2016171
3 2020120
4 200954
5 201536
6 202513
7 202212
8 202311
9 20239
10 20255
11 20234
12 20223
13 20223
14 20141
15 20221
16 20251

About Silu Yang

Silu Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Developmental Neuroscience, Obstetrics and Gynecology and Immunology, having authored 16 papers that have together received 630 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Gastric Cancer Management and Outcomes (3 papers), Epigenetics and DNA Methylation (1 paper), Genomics and Chromatin Dynamics (1 paper), Enhanced Recovery After Surgery (1 paper), T-cell and B-cell Immunology (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper) and Mosquito-borne diseases and control (1 paper). The work is most often cited by research in Oncology (188 citations), Developmental Neuroscience (19 citations), Pulmonary and Respiratory Medicine (142 citations), Otorhinolaryngology (22 citations) and Public Health, Environmental and Occupational Health (129 citations). Silu Yang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Stephanie A. Herrlinger, Fan Lai, Jian-Fu Chen, Melinda Ann Brindley, Qiang Shao, Julie M. Moore, Ye Shen, Ying Wang, Qun He and Jiyong Wang. Their work appears in journals such as Advances in Therapy, Digital Signal Processing, Gynecologic Oncology, British Journal of Cancer and Theoretical Computer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact